Pharmaceutical company Inotiv has notified the US Securities and Exchange Commission (SEC) that its business operations took a hit after hackers compromised and encrypted its internal systems. The incident, the organization said in a Form 8-K filing, occurred on 08 August 2025, and prompted Inotiv to initiate containment and remediation processes. “The company’s preliminary investigation determined that a threat actor gained unauthorized access to, and encrypted certain of, the company’s system
qilin (4)
A ransomware attack has forced drug research firm Inotiv to shut down critical systems, resulting in operational disruptions. Inotiv is an analytical drug discovery and development service that works with various pharmaceutical companies. It employs over 2,000 research specialists and reports an annual revenue of over $500 million. According to a regulatory filing with the US Securities and Exchange Commission (SEC), Inotiv discovered the cyber attack on 8 August. “On August 8, 2025, Inotiv,
More than 1,000 planned operations and over 3,000 outpatient appointments have been postponed amid ongoing disruption caused by a cyber-attack that impacted London hospitals. Synnovis, an agency which manages labs for NHS trusts and GPs in south-east London, was the victim of a data hack on 3 June.[1]
New figures from NHS England show that since then, 3,396 appointments and 1,255 elective procedures have been postponed. In a statement, the chief executives of two affected trusts said they were
Cyber security researchers infiltrated the Qilin ransomware group, gaining an inside look at how the gang functions and how it rewards affiliates for attacks. The ransomware-as-a-service group (RaaS), also known by the name “Agenda”, initially emerged in July 2022, attacking a slate of healthcare organizations, tech companies and more across the world. They have victimized at least 12 organizations since July 2022 from Canada, the US, Colombia, France, Netherlands, Serbia, the United Kingdom a
